Argus Research Maintains Buy on Corteva, Raises Price Target to $91

Argus Research analyst Bill Selesky has maintained a Buy rating on Corteva (NYSE: CTVA) and increased the price target from $80 to $91. This adjustment reflects a positive outlook on the company's performance.